Alloy’s menopause-care pages describe a doctor consultation alongside a menu of hormone products. Reading those pages together is important: the fee for the assessment and the starting price for a prescription refer to different parts of the process. Neither number alone gives every reader a complete cost.

We checked Alloy’s hormone-therapy and doctor-consultation pages October 3, 2026. This is a review of published information, not a treatment experience or an audit of clinical results. We do not repeat its marketing outcome percentages as evidence of what a particular reader should expect.

Blank medicine carton and folded leaflet beside a glass of water and pink pen
Original editorial illustration.

The consultation has a stated fee

The doctor-consultation page lists a one-time $49 consultation fee. It also describes ongoing unlimited messaging if the patient purchases a prescription. The purchase condition matters: a reader should not assume that paying the consultation fee alone provides every ongoing service described elsewhere on the page.

Ask what happens if no prescription is issued, whether the consultation fee is refundable in that situation, and how later assessments are handled. A clinical assessment is not a guarantee of medication eligibility. Confirm the current process, your location, and any limits before paying.

The hormone products have separate starting prices

At the time checked, Alloy’s hormone page listed estradiol patches starting at $74.99 per 30 days, oral estradiol at $39.99 per 30 days, and gel or spray at $69.99 per 30 days. These are product starting prices. They should not be treated as the final total for every possible regimen.

If progesterone or another prescription is proposed, ask for its separate cost and the reason it is part of the plan. Confirm the supply duration, amount collected at checkout, shipping, renewals, and consultation charges. A 30-day equivalent does not establish the billing interval without the checkout terms.

Compare exact forms with current labels

A patch, pill, gel, or spray cannot be selected simply by finding the smallest price. Ask which product is appropriate for the clinical purpose and your history. The FDA’s current label-change announcement is also a reason to use the exact current product information rather than an older screenshot of general hormone-therapy warnings.

CoreAge’s estrogen menu also describes several forms, while its progesterone page identifies a compounded oral option. Those differences deserve questions about exact ingredients, approval status, manufacturer or pharmacy, and follow-up. A familiar ingredient name does not settle the whole comparison.

Our view of the provider menu

Alloy gives readers visible consultation and product starting figures that can support a useful cost conversation. The remaining work is to confirm the exact prescription, current availability, state eligibility, and complete charge. We have not independently audited those details for every state or patient circumstance.

CoreAge Rx is our first featured care option, and Midi offers a separately described visit and insurance structure. Read each provider note with the same questions in hand. A clear comparison respects the differences between their services instead of declaring one clinically superior from a public price table.

Sources for this story

Public pages are a dated snapshot. A provider page supports its published description, not a clinical outcome or a completed service audit.